In this way, the discrepancy in the PD-L1 assay sensitivity and precision might compromise the accuracy of PD-L1 detection in clinical practice and clinical research, which should also be noted by the clinicians in further studies of cervical cancer. This evidence concerns the gene CD274 and cervical cancer.